Showing results (1-10 of 410) with videos related to
Sort By:
Pageof 41
Klinische Padiatrie|July 1, 1994
[Recommendation for studies of optimizing therapy protocols]U Creutzig, K WinklerLeukemia & Lymphoma|May 11, 2002
Isolated myelosarcoma in children--update and reviewD Reinhardt, U CreutzigDeutsche Medizinische Wochenschrift (1946)|August 8, 1980
[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)]U Creutzig, G SchellongBlood|May 15, 1990
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study GroupU Creutzig, J Ritter, G SchellongHaematology and Blood Transfusion|January 1, 1987
Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16F Berthold, U Creutzig, F LampertMedical Oncology and Tumor Pharmacotherapy|January 1, 1985
Treatment of acute myelogenous leukemia in childrenG Schellong, U Creutzig, J RitterKlinische Padiatrie|April 29, 2005
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blastsC Langebrake, U Creutzig, D ReinhardtLeukemia|January 1, 1992
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-GroupJ Ritter, U Creutzig, G SchellongKlinische Padiatrie|February 2, 2002
[Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation]D Reinhardt, C Thiele, U Creutzig, et al.Pageof 41